Key facts
- Notable investors include Kswan Ventures, University of Charleston.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for MitRx Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for MitRx Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MitRx Therapeutics
Developer of drugs intended to find novel services to treat skin diseases, improve patient outcomes and enhance quality of life. The company offers drug candidates with enhanced pharmacokinetic properties for skin diseases, enabling patients to achieve improved treatment outcomes and an enhanced quality of life.
- Sector
- Healthcare
- HQ
- Charleston, SC, United States
- Founded
- 2021
- Website
- mitrxtherapeutics.com/
- Ownership
- Privately Held (backing)
MitRx Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MitRx Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MitRx Therapeutics in its N-PORT filings yet. We sweep new filings monthly.